insights_auto
Why is MNKD up 3.74%?
Dive Deeperchevron_right
MNKD:NASDAQ
MannKind Corp
$3.46
arrow_upward
+3.74%(+0.12) 1D
Sep 30, 11:19:48 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.37
High
$3.48
Low
$3.30
Mkt. cap
1.11B
Avg. vol.
3.81M
Volume
531.31K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
Open
$3.37
High
$3.48
Low
$3.30
Mkt. cap
1.11B
Avg. vol.
3.81M
Volume
531.31K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
AD HOC NEWS
·
21 hours ago
MannKind stock adds an inhaled GLP-1 licensing deal
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com